Stay Informed

Memory Enhancement Center

↑ Grab this Headline Animator

Enter your email address:

Delivered by FeedBurner

Medical Links

Links

Search


 
Joel S. Ross, MD, FACP, AGSF, CMD President and Founder of Memory Enhancement Center of America
 

Joel S. Ross, MD

MD FACP AGSF CMD CPI
President and Founder
 
Memory Enhancement Center
of America, Inc.
4 Industrial Way West, 2nd Floor
Eatontown, New Jersey 07724
732.571.1535
 

Uncategorized

« Previous Entries

Possible Huge Breakthrough in non-invasive detection of Amyloid

Tuesday, July 27th, 2010

For many years scientists have been focusing on finding non invasive ways to locate the “holy grail” of Alzheimer’s Disease (or what I have referred to as “amyloid associated memory impairment, AAMI). Perhaps finally we have arrived. Please read below:
Honolulu: FDA Approval in Sight for 18F Amyloid Tracer Florbetapir?
13 July 2010. [...]

AVID may hit a Home Run in Preventing Alzheimer’s Disease

Friday, June 25th, 2010

Promise Seen for Detection of Alzheimer’s
I have been blogging quite often on the topic of “amyloid” buildup in the brains of patients with Alzheimer’s Disease and for those who have no memory loss (yet) but with amyloid detected in the brain. What good is it to know you might ask, that this sticky/gooey material [...]

Mild Cognitive Impairment

Thursday, June 24th, 2010

Below is an excerpt from arguably one of the leading experts in the field of MCI. The sooner we seek treatment for memory loss, the better the outcome.
Mild cognitive impairment: A way station along road to Alzheimer’s
By Angela Lunde
(Ronald Petersen, M.D., Ph.D., is the director of the Mayo Clinic Alzheimer’s Disease Research Center. Below [...]

Does Gingko do any good at all?

Wednesday, June 23rd, 2010

Many of my patients take Gingko despite no FDA approval for this supplement.
Many studies have shown convincingly it is worthless to take as well as expensive. Now another study is published which claims to have a huge protective effect compared to placebo in a four year followup of 2584 patients with “memory loss”. [...]

Therapeutics in Alzheimer’s Disease

Monday, June 7th, 2010

I have attached a copy of a section covering current treatments for AD reprinted from the following article:
My take on this approach is as follows: Similar to Baxter’s approach using their “Gamma Guard” it will take time to determine if this approach is truly meaningful to patients.
AMYLOID-TARGETED THERAPEUTICS IN ALZHEIMER’S DISEASE: USE OF HUMAN ALBUMIN [...]

« Previous Entries